Effect of L-carnitine on acetyl-CoA content and activity of blood platelets in healthy and diabetic persons

Clinical Chemistry

Volumn 51, Issue 9, 2005, Pages 1673-1682

  Michno, Anna ^a   Raszeja Specht, Anna ^a   Jankowska Kulawy, Agnieszka ^a   Pawełczyk, Tadeusz ^a   Szutowicz, Andrzej ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; CARNITINE; CARNITINE ACETYLTRANSFERASE; FATTY ACID SYNTHASE; FRUCTOSAMINE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A1C; MALONALDEHYDE; OXOGLUTARATE DEHYDROGENASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DIABETIC ANGIOPATHY; ENZYME ACTIVITY; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA; PROTEIN DETERMINATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ACETYL COENZYME A; ADULT; BLOOD PLATELETS; CARNITINE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; PLATELET AGGREGATION; REFERENCE VALUES;

EID: 24144502077     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.050328     Document Type: Article

References (32)

1. Trovati M, Anfossi G. Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells. Diabetologia 1998;41:609-22.
2. Winocour PD. Platelet abnormalities in diabetes mellitus. Diabetes 1992;41:26-31.
3. Bremer J. Carnitine-metabolism and functions. Physiol Rev 1983;63:1420-80.
4. Pearce NJ, Yates JW, Berkhout TA, Jackson B, Tew D, Boyd H, et al. The role of ATP-citrate lyase in the metabolic regulation of plasma lipids. Biochem J 1998;334:113-9.
5. Sullivan AC, Hamilton JG, Miller ON, Wheatley VR. Inhibition of lipogenesis in rat liver by (-)hydroxycitrate. Arch Biochem Biophys 1972;150:183-90.
6. Szutowicz A, Tomaszewicz M, Bielarczyk H. Disturbances of acetyl-CoA, energy and acetylcholine metabolism in some encephalopathies. Acta Neurobiol Exp 1996;56:323-39.
7. Bielarczyk H, Tomaszewicz M, Madziar B, Ćwikowska J, Pawełczyk T, Szutowicz A. Relationships between cholinergic phenotype and acetyl-CoA level in hybrid murine neuroblastoma cells of septal origin. J Neurosci Res 2003;73:717-21.
8. Sheperd PR, Kahn BB. Glucose transporters and insulin action. N Engl J Med 1999;341:248-57.
9. Craik JD, Stewart M, Cheeman CI. GLUT-3 (brain-type) glucose transporter polypeptides in human blood platelets. Thromb Res 1995;79:461-9.
10. Michno A, Skibowska A, Raszeja-Spech A, Ćwikowska J, Szutowicz A. The role of adenosine triphosphate-citrate lyase in metabolism of acetyl-coenzyme A and function of blood platelets in diabetes mellitus. Metabolism 2004;53:66-72.
11. Skibowska A, Raszeja-Spech A, Szutowicz A. Platelet function and acetyl-coenzyme A metabolism in type 1 diabetes mellitus. Clin Chem Lab Med 2003;41:1136-43.
12. Pignatelli P, Lenti L, Sanguigni V, Frati G, Simeoni I, Gazzaniga PP, et al. Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress. Am J Physiol Heart Circ Physiol 2003; 283:H41-8.
13. Triggiani M, Oriente A, Golino P, Gentile M, Battaglia C, Brevetti G, et al. Inhibition of platelet activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. Biochem Pharmacol 1999;58:1341-8.
14. Ishikura H, Takeyama N, Tanaka T. Effects of 2-tetradecylglycidic acid on rat platelet energy metabolism and aggregation. Biochim Biophys Acta 1992;1128:193-8.
15. Willoughby SR, Chirkov YY, Kennedy JA, Murphy GA, Chirkova LP, Horovitz JD. Inhibition of long-chain fatty acid metabolism does not affect platelet aggregation responses. Eur J Pharmacol 1998; 356:207-13.
16. Ricny J, Tucek S, Novakova J. Acetylcarnitine, Carnitine and glucose diminish the effect of muscarinic antagonist quinuclidynyl benzilate on striatal acetylcholine content. Brain Res 1992;576: 215-9.
17. Alberts AW, Ferguson K, Hennessy S, Vagelos PR. Regulation of lipid synthesis in cultured animal cells. J Biol Chem 1974;249: 5241-9.
18. Pawełczyk T, Angielski S. Cooperation of Ca and pH in regulation of the activity of the 2-oxoglutarate dehydrogenase complex and its components from bovine kidney cortex. Acta Biochim Pol 1984;3:289-305.
19. Edwards YH, Chase JFA, Edwards MR, Tubss PK. Carnitine acetyltransferase: the question of multiple forms. Eur J Biochem 1974;46:209-15.
20. Glock GE, McLean P. Further studies on the properties and assay of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase in rat liver. Biochem J 1953;55:400-8.
21. Wright JA, Maeba P, Sanwall BD. Allosteric regulation of the activity of citrate synthase of Escherichia coli by α-ketoglutarate. Biochem Biophys Res Commun 1967;29:34-40.
22. Kawasaki K, Miyano M, Hirase K, Iwamoto M. Amino acids and peptides. XVIII. Synthetic peptides related to N-terminal portion of fibrin α-chain and inhibitory effects on fibrinogen/thrombin clotting. Chem Pharm Bull 1993;41:975-7.
23. Szutowicz A, Bielarczyk H. Elimination of CoASH interference from acetyl-CoA cycling assay by maleic anhydride. Anal Biochem 1987;164:292-6.
24. Bielarczyk H, Szutowicz A. Evidence for the regulatory function of synaptoplasmic acetyl-CoA in acetylcholine synthesis in nerve endings. Biochem J 1989;262:377-80.
25. Pense M, Black H, Fuster W, Mest H. An improved malonyl dialdehyde assay for estimation of thromboxane synthetase activity in washed human blood platelets. Prostaglandins 1985;30: 1031-8.
26. Bradford M. A rapid sensitive method for the quantitation of microgram quantities of protein using principle of dye protein binding. Anal Biochem 1976;21:248-54.
27. Girard J. Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Annu Rev Nutr 1997;17:325-52.
28. Iida N, Iida R, Takeyama N, Tanaka T. Increased platelet aggregation and fatty acid oxidation in diabetic rats. Biochem Mol Biol Int 1993;30:177-85.
29. Holmsen H. Biochemistry and function of platelets. In: Williams WJ, ed. Hematology. New York: McGraw-Hill, 1997:1182-243.
30. Wachowicz B, Olas B, Zbikowska HM, Buczyński A. Generation of reactive oxygen species in blood platelets. Platelets 2002;13: 175-82.
31. Jain SK, Krueger KS, McVie R, Jaramillo JJ, Palmer M, Smith T. Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients. Diabetes Care 1998;21:1511-6.
32. Vericel E, Januel C, Carreras M, Moulin P, Lagarde M. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes 2004;53:1046-51.